Evaluation of Safety of a Newly Formulated Pirfenidone in Chronic Kidney Disease: A Non-Randomized Pilot Study in Mexican Patients

The aim of this pilot clinical trial was to evaluate the safety of a new formulation of prolonged-release Pirfenidone (PR-PFD) in chronic kidney disease (CKD), specifically focal and segmental glomerular hyalinization (FSGH). Open-label, pilot, nonrandomized trial. Eighteen patients previously diagn...

Полное описание

Библиографические подробности

Главные авторы:	Simón A. Ojeda-Duran, Iván Lyra-Gonzalez, Alejandra Meza-Rios, Silvia Lucano-Landeros, Ana Sandoval-Rodriguez, Monica Vazquez-Del Mercado, Arturo Santos, Lucia Flores-Contreras, Juan Armendáriz-Borunda
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Troika Publisher 2020-05-01
Серии:	Journal of Renal and Hepatic Disorders
Предметы:	Chronic Kidney Disease glomerular filtration rate prolonged-released Pirfenidone.
Online-ссылка:	https://jrenhep.com/index.php/jrenhep/article/view/61
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!